Mark Corrigan, Director at Cubist Pharma, holds 7.20K shares in Nabriva Therapeutics (Ticker: NBRVF), holds 0.00 shares in Cubist Pharma (Ticker: CBST), holds ― shares in Novelion Therapeutics (Ticker: NVLNF). Most recently, Mark Corrigan Sold ― shares of Nabriva Therapeutics on Aug 04, 2022 for an estimated value of 1.96K.